baber/WOPTO huggingface dataset:
Patent FI-920343-A0 (FI)
Inventor: LANG HARTMUT
IPC: C12Q1/56
Filed: 1992-01-24
Abstract: To determine factor VIII activity in a sample by reaction with a reagent containing thrombin, factor IXa beta , phospholipids and calcium ions in order to form a complex which contains factor VIIIa, factor IXa, phospholipid and calcium ions, reaction of this complex with factor X in order obtain activated factor X, furthermore reaction of the resulting factor Xa with a chromogenic substrate to form a substance which can be determined by spectrophotometry, the complex formation and the activation of factor X are carried out in one stage by adding to the sample as complex-forming reagent a mixture of human thrombin, phospholipids, calcium ions, human factor IXa beta , human factor X and, where appropriate, human factor XIa and human factor XIIa.
Patent FI-922770-A0 (FI)
Inventor: MOORE KEVIN W
IPC: C12N5/10
Filed: 1992-06-16
Abstract: BCRF1 proteins are provided for treating conditions associated with excessive production of IFN- gamma . Also provided are expression vectors for producing BCRF1 proteins. Compositions of the invention are useful in treating a variety of disorders, including allergy, psoriasis, tissue rejection, and MHC-linked autoimmune diseases.
Patent FI-932321-A0 (FI)
Inventor: MAEDER CARL CONRAD
IPC: G05B19/418
Filed: 1993-05-21
Abstract: A safety cut-off system for an installation consisting of machines which are designed for interaction has a machine cut-off level (10) in which a dedicated cut-off circuit is allocated to each machine (12a-12h), a zone cut-off level (20) in which cut-off zones can be cut off which consist of groups of associated machines, and a system cut-off level (30) which is allocated to all the machines (12a-12h) in the installation. The cut-off circuits each have an electrically operable switching element (16a-16h) which is connected via safety circuits (13a-13d) to a main box (24) for central control of the safety cut-off system and, through said box, to a power supply (100). The safety circuits (13a-13d) have operable tripping elements (22a, 22b, 32a) at the zone cut-off level (20) and at the system cut-off level (30), are designed as latching circuits and are passed through by the main box in which they can be selectively linked with one another by means of a switching matrix such that groups of associated machines are cut off when one of the tripping elements is operated. In order to connect an additional machine to the safety cut-off system, it is necessary only to connect the cut-off circuit of this machine to the main box (24) via an additional latching circuit. There is no need for any other change to the wiring of the installation since the additional machine is linked to the safety cut-off system in the switching matrix of the main box (24). <IMAGE>
Patent FI-940844-A0 (FI)
Inventor: BABUCKE DIETER
IPC: D21H23/00
Filed: 1994-02-23
Abstract: A doctor bar, in particular for dosing coating slips on continuous webs of paper or cardboard or rubber coatings on cylinders, is characterized in that at least the superficial area which forms the doctoring or dosing surface is made of glass or carbon fiber or of plastic fiber(s) reinforced by glass or carbon fiber(s).
Patent FI-941637-A0 (FI)
Inventor: WHEATLEY CHARLES E
IPC: H04J13/00
Filed: 1994-04-08
Abstract: A power control system for a cellular mobile telephone system in which system users communicate information signals between one another via at least one cell site using code division multiple access spread spectrum communication signals. The power control system controls transmission signal power for each cellular mobile telephone in the cellular mobile telephone system wherein each cellular mobile telephone has an antenna, transmitter and receiver and each cell-site also has an antenna, transmitter and receiver. Cell-site transmitted signal power is measured as received at the mobile unit. Transmitter power is adjusted at the mobile unit in an opposite manner with respect to increases and decreases in received signal power. A power control feedback scheme may also be utilized. At the cell-site communicating with the mobile unit, the mobile unit transmitted power is measured as received at the cell-site. A command signal is generated at the cell-site and transmitted to the mobile unit for further adjusting mobile unit transmitter power corresponding to deviations in the cell site received signal power. The feedback scheme is used to further adjust the mobile unit transmitter power so that mobile unit transmitted signals arrive at the cell-site at a desired power level.
Patent FI-945593-A0 (FI)
Inventor: KAAS SUSAN MARY
IPC: A61K31/66
Filed: 1994-11-28
Abstract: Compounds of the formula   <IMAGE>   where m and n are integers 0 to 10 and m+n equals 0 to 10, (a) X is O or S (b) Z is a covalent bond; a monocyclic or polycyclic carbocycle ring moiety; or a monocyclic or polycyclic heterocyclic ring moiety containing one or more heteroatoms selected from O, S, or N; (c) Q is covalent bond; O; or S; (d) R is COOH, SO3H, PO3H2, or P(O)(OH)R4, wherein R4 is C1-C8 alkyl; (e) R1, R2 and R5 are as defined in the claims. are useful in the treatment of calcium and phosphate elated disorders, such as arthritis and the like.
Patent FI-950240-A0 (FI)
Inventor: LANG FRITZ
IPC: A63C7/10
Filed: 1995-01-20
Abstract: The device comprises a box (2) containing the longitudinal support (3), held in a cavity (10) and has inner surfaces (28) guiding the support in the latter swivel part (37). The front end of the box has a link element (23) interacting with the link. The adjustment (5) consists of a lever (51) in a plinth (4) and possessing an eccentric inner surface on which rests a pin (38) cooperating with a connecting element (30). The adjusting lever has at least a partly cylindrical outer surface (54) having a peripheral hole for the connecting element.
Patent FI-954603-A0 (FI)
Inventor: CASETTA CLAUDIO
IPC: B61F5/22
Filed: 1995-09-28
Abstract: A railway vehicle (F) having a variable trim body (1), comprising two bogies (2, 2) with respective swinging transverse members (5) pivotally connected to the body (1), and a control system for controlling roll of the body (1) about its longitudinal axis, by means of linear actuators (11) interposed between the swinging transverse members (5) and the opposite sides of the body (1) and operated through a regulation electronic unit (5) connected to first transducer means (16) detecting the non-compensated centrifugal acceleration acting on the body (1), and to second transducer means comprising at least two angular transducers (17) for detecting the momentary relative angle between each swinging transverse member (5) and the body (1). <IMAGE>
Patent FI-955227-A0 (FI)
Inventor: BRUEGGEMANN HELMUT
IPC: C08L1/28
Filed: 1995-11-01
Abstract: PCT No. PCT/EP93/01060 Sec. 371 Date Jan. 26, 1996 Sec. 102(e) Date Jan. 26, 1996 PCT Filed May 3, 1993 PCT Pub. No. WO94/25519 PCT Pub. Date Nov. 10, 1994A polymer composition, in particular an absorbent composition or an active substance-containing depot material are disclosed which substantially consist of a water-soluble and/or water-swellable polymer based on polysaccharides as the main component, and of a water-swellable polymer as further component, used as polymeric components, and of a matrix material for the prevention of separation and gel blocking, an ionic or covalent cross-linking agent, a reactive additive, as well as of an anti-blocking agent. Additionally, their production and use as well as (animal) hygiene items and chemico-technical products are disclosed which comprise these polymer compositions or absorbent compositions.
Patent FI-955824-A0 (FI)
Inventor: HAMMARSTEDT GOESTA LEOPOLD
IPC: E03D1/12
Filed: 1995-12-04
Abstract: The invention relates to an actuating mechanism for a flushing system having an outlet device (11) arranged in a flush cistern (10) and an inlet device (48). This inlet device has a float device (40) for controlling the supply of liquid into the flush cistern (10) by an inlet valve (48) included in the inlet device (48). The float (40) of said float device is operatively connected to the inlet valve (48) via a link system (47) for opening and closing the inlet valve (48) depending on the liquid level in the flush cistern. The outlet device (11) of the actuating mechanism comprises a release means (49) for opening the outlet valve (11) of the outlet device. According to the invention, the actuating mechanism has a locking device (54-62) for preventing the initiation of a new flushing operation before the flush cistern (10) has again been filled with liquid to above a predetermined minimum level. <IMAGE>
Patent FI-961162-A0 (FI)
Inventor: LINDAHL LENNART
IPC: A23L7/104
Filed: 1996-03-13
Abstract: PCT No. PCT/SE94/00857 Sec. 371 Date Nov. 21, 1995 Sec. 102(e) Date Nov. 21, 1995 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/07628 PCT Pub. Date Mar. 23, 1995A homogeneous and stable cereal suspension having the taste and aroma of natural oats, as well as a method for the preparation thereof, is described. The cereal suspension contains intact  beta -glucans from the starting material and is prepared by A) dry- or wet-grinding rolled oats or otherwise heat- and water-treated oats to meal, B) suspending the oatmeal in water, if the meal has been produced by dry grinding, C) optionally centrifuging or decanting the suspension in order to remove coarse fibre particles, D) treating the suspension with  beta -amylase, which specifically gene-rates maltose units and has no glucanase and proteinase effect, to a viscosity of 3-0.1 Pas in the shear rate range of 10-100 s-1, E) treating the suspension with  alpha -amylase, which specifically gene-rates maltose units and has no glucanase and proteinase effect, to a viscosity of <0.5 Pas in the shear rate range of 10-100 s-1, F) preferably homogenising the enzyme-treated suspension, and G) subjecting the suspension to UHT treatment (UHT=Ultra High Temperature) in order to obtain a sterile product while inactivating the enzymes added.
Patent FI-961234-A0 (FI)
Inventor: FROST JOHN W
IPC: C12P7/44
Filed: 1996-03-15
Abstract: A method is provided for producing adipic acid. The method comprises the steps of culturing a cell transformant capable of converting a carbon source to catechol for a period of time sufficient to convert said carbon source to catechol, biocatalytically converting the catechol to cis, cis-muconic acid using catechol 1,2-dioxygenase, and hydrogenating the cis, cis-muconic acid to produce adipic acid. Also provided is a heterologous transformant of the host cell having an endangeous common pathway of aromatic amino acid biosynthesis. The heterologous transformant is characterized by the constitutive expression of structural genes encoding 3-dehydroshikimate dehydratase, protocatechuate decarboxylase, and catechol 1,2-dioxygenase.
Patent FI-962953-A0 (FI)
Inventor: ZIEGLER HUGO
IPC: C07D317/56
Filed: 1996-07-24
Abstract: PCT No. PCT/EP95/00146 Sec. 371 Date Jul. 22, 1996 Sec. 102(e) Date Jul. 22, 1996 PCT Filed Jan. 16, 1995 PCT Pub. No. WO95/20569 PCT Pub. Date Aug. 3, 1995Process for the preparation of 2-methoxyimino-2-arylacetic esters of formula (I) in which R is C1-C12alkyl, which comprises reacting an appropriately substituted boronic acid of general formula (II) or the trimeric form (lII) herein, which is in equilibrium with it, in the presence of a Pd catalyst, with a methoxyiminoacetic ester of formula (IV) in which R is C1-C12alkyl and X is a leaving group. According to a further process variant, in principle the groups which split off the two reactants may change places. The process can be applied not only to phenyl derivatives but also to larger ring systems (naphthyl, pyridyl, heterocycles).
Patent FI-964346-A0 (FI)
Inventor: KOSKINEN JUKKA
IPC: B05C5/02
Filed: 1996-10-28
Abstract: The invention relates to a method and assembly for coating a moving web (1) of paper or paperboard by means of a coating mix jet which is directed to the surface of the web (6) without mechanical support. The invention is based on applying a desired amount of the coating mix to the web (1) via a narrow-gap slit orifice (5), and by virtue of measuring the coat weight on the web (1), adjusting the position of at least one lip (4) of the slit orifice (5) in order to achieve the desired weight and cross-machine profile of the applied coat. <IMAGE>
Patent IL-61424-A0 (IL)
Title: Preparation of a benzofuran derivative
IPC: C07D307/86
Filed: 1980-11-06
Abstract: Process for the preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran from ortho-methallyloxyphenol or ortho-methallylpyrocatechol. It consists in heating ortho-methallyloxyphenol or ortho-methallylpyrocatechol in the presence of an aluminum derivative. 2,3-Dihydro-2,2-dimethyl-7-hydroxybenzofuran can be used for the synthesis of carbofuran, which is a polyvalent insecticide.
Patent IL-70047-A0 (IL)
Title: Microbial production of indigo
IPC: C12N15/09
Filed: 1983-10-25
Abstract: There is provided a DNA transformation vector comprising DNA sequences coding for microbial synthesis of an aromatic dioxygenase and tryptophanase enzymes, preferably wherein the DNA sequences are under the control of the same promoter/regulator DNA sequence.
Patent IL-88400-A0 (IL)
Title: Monoclonal antibody recognizing alpha 2-3 bonds
IPC: C07K16/32
Filed: 1988-11-17
Abstract: A hybridoma capable of procuding a monoclonal antibody specific to a sialic acid containing glycolipid carrying N-acetylneuraminic acid residue having alpha 2---> 3 linkage is herein disclosed. The hybridoma can be generated by fusing (i) B cells or lymphocytes obtained by immunizing an animal with a sialic acid containing glycolipid carrying N-acetylneuraminic acid residue having alpha 2---> 3 linkage and (ii) myeloma cells. The monoclonal antibody produced by the hybridoma can be used for purifying gangliosides, for treating patients suffering from melanoma and for diagnosing sera.
Patent IL-92404-A0 (IL)
Title: Transportable construction element in the form of a container
IPC: E04B1/344
Filed: 1989-11-22
Abstract: Transportable construction element in the form of a container (1), comprising at least one hinged panel (4) capable of pivoting between a closed position and an open position swung outwards, as well as an internal structure (11) open downwards, comprising an upper panel (12), a front panel (13) and at least two side panels (14) and having a rear opening opposite the said front panel. This internal structure is supported by the container so as to be movable along a path (F), between an inserted position, situated inside the container, and an extended position, in which the hinged panel of the container forms a floor for the internal structure.
Patent IL-95739-A0 (IL)
Title: Radiation-polymerizable mixture and process for producing a solder resist mask
IPC: C08G59/18
Filed: 1990-09-19
Abstract: A description is given of a radiation-polymerisable composition which contains a polymerisable compound, a polymeric binder containing units of methacrylic acid, a methacrylate and a styrene, the latter in a proportion of 40 to 65% by weight, a finely divided mineral pigment with a silicic acid or silicate base, a photopolymerisation initiator, a compound containing at least two epoxy groups in the molecule and a thermal hardener for epoxy groups. The composition is suitable in particular for producing solder resist masks and, after exposure to an image and development, can be cured by heating to 80 to 150 DEG C to form a template which is resistant under soldering conditions.
Patent IL-96239-A0 (IL)
Title: Novel insulin derivatives,process for their preparation,their use and pharmaceutical preparations containing them
IPC: C12P21/02
Filed: 1990-11-05
Abstract: Insulin derivatives of the formula III 
<IMAGE>
 in which 
 
  a) R<30> + R<31> together = OH or 
  b) R<30> = residue of a neutral, genetically encodable L-amino acid and R<31> = OH or
 a physiologically acceptable organic group which is basic in nature and has up to 50 C atoms, in whose structure 0 to 3  alpha -amino acids are involved and whose optionally present terminal carboxyl group can be free, in the form of an ester, of an amide or of a lactone, or reduced to CH2OH, and 
  c) R<A-1> = residue of a genetically encodable L-amino acid or a physiologically acceptable organic group with up to 50 C atoms, with the exception of the cases in which simultaneously R<30> = Ala, R<31> = OH, R<A-1> = Lys or Arg, and the A chain and B chain are the sequences of bovine insulin, 
 and the physiologically tolerated salts thereof. 
<??>The compounds are suitable for the treatment of diabetes mellitus, have a delayed action profile and are very well tolerated.
Patent AU-PQ619400-A0 (AU)
Title: Titanium dioxide coated product
IPC: C09C1/40
Filed: 2000-03-10
Abstract: A composition of matter comprises particles each having a substrate being an oxide or other suitable compound of a metal other than titanium or of certain non-metal elements, and a coating on said substrate being a layer of titanium dioxide. A method of forming particles of titania-coated substrate, includes contacting a bed of hydrated particles of an oxide or other suitable compound of a metal other than titanium or of certain non-metal elements with a fluid medium containing flowing titanium tetrachloride, under conditions in which a layer comprising one or more involatile oxychloride or oxide compounds is formed at and below the surface of each of a multiplicity of the particles of the oxide or other suitable compound which thereby provides a substrate for the layer. The oxychloride or oxide compound or compounds are treated to convert the layer to a Titania coating on the particles.
Patent AU-PS070602-A0 (AU)
Title: Timing gates for a packaging machine
IPC: B65G11/00
Filed: 2002-02-22
Abstract: A chute assembly (11) to be positioned between a weigher (10) and a former (12) of a packaging machine. The chute assembly (11) includes a timing gate device (23) including a plurality of timing gates (25) that regulates the delivery of batches of product from the weigher (10) to the former (12). The gates (25) are driven between a first position at which they inhibit the delivery of batches of product to the former (12), and a second position permitting the flow of batches of product to the former (12). <IMAGE>
Patent FI-20000944-A0 (FI)
Inventor: KIRJAVAINEN KARI
IPC: B29C48/525
Filed: 2000-04-19
Abstract: An extruder includes a material feeding device feeding into a radial pump unit. The radial pump unit includes conical screws which are adjacently positioned and rotate in the same direction. The radial pump unit transfers an annular flow of the material into the extruder's nozzle. Additional material can be supplied into the product through the radial pump unit.
Patent IL-100105-A0 (IL)
Title: Supported microspheres
IPC: B01J47/00
Filed: 1991-11-20
Abstract: A composition of matter which comprises a solid substrate having covalent bonds to either (a) substantially a single layer of at least one species of microspheres containing residual reactive functions, or (b) a multiplicity of layers of at least one species of microspheres, wherein adjoining layers of the multiplicity of layers are covalently linked together, the innermost layer of the multiplicity of layers having the above-mentioned covalent bonds to the solid substrate connected thereto, while at least the outermost layer of the multiplicity of layers contains residual reactive functions. The covalent bonds may be provided by the same or different ligands. The compositions find potential applications not only where the use of microspheres is already known per se, but may also be used to immobilize drugs, prodrugs, enzymes, proteins, antibodies, biological cells and other controllably releasable substances.
Patent IL-100731-A0 (IL)
Title: Mixed specificity fusion protein and pharmaceutical composition containing it
IPC: C07K16/28
Filed: 1992-01-22
Abstract: Mixed specificity fusion proteins capable of binding to cellular adhesion molecules have been produced. The fusion proteins contain a polypeptide region, such as an IgG constant region, operatively attached to at least two binding regions each of which corresponds to either an extracellular domain of a cell surface receptor for cellular adhesion molecules, or a variable region of an antibody directed to a cellular adhesion molecule. A method of inhibiting inflammation is a patient is disclosed in which the present fusion proteins are administered to a patient to inhibit the attachment of inflammatory cells to vascular endothelium. A method of inhibiting metastasis is disclosed in which the present fusion proteins are administered to a patient to inhibit the metastasis of responsive tumor cells.
Patent IL-107842-A0 (IL)
Title: Hydroxyamidine derivatives
IPC: A61P9/08
Filed: 1993-12-02
Abstract: The invention relates to the compounds of the formula I <CHEM> wherein the C(=NOH)-NH2 group may be in tautomeric form; and pharmaceutically acceptable salts thereof, in which:  R1 is amino or amino which is mono- or disubstituted X1 and X3, independently of one another, are oxygen (-O-) or sulphur (-S-); and X2 is a divalent aliphatic hydrocarbon radical which may be interrupted by an aromatic radical; The compounds are useful, for example, as selective LTB4 receptor antagonists in the treatment of conditions or syndromes in mammals which are responsive to LTB4 receptor antagonism. They are prepared in a manner known per se.
Patent IL-114659-A0 (IL)
Title: Catalysts for the polymerization of olefins and their uses
IPC: C08F10/02
Filed: 1995-07-19
Abstract: Catalysts for the polymerization of olefins which comprise the reaction product of (a) a bridged and/or substituted cyclopentadienyl compound of titanium, zirconium, or hafnium; (b) an organometallic aluminum compound of formula Al(CH2-CR4R5R6)wR7yHz, wherein in the (CH2-CR4R5R6) groups, which are the same or different, R4 is an alkyl, alkenyl or arylalkyl group having from 1 to 10 carbon atoms, R5 is an alkyl, alkenyl, aryl, arylalkyl or alkylaryl group having from 3 to 50 carbon atoms and, optionally, R4 and R5 can be fused together to form a ring having from 4-6 carbon atoms, R6 is hydrogen or an alkyl alkenyl or arylalkyl group having from 1 to 10 carbon atoms, the R7 substituents, the same or different, are alkyl, alkenyl, aryl, arylalkyl or alkylaryl radicals having from 1 to 10 carbon atoms and, optionally, can contain Si or Ge atoms, w is 1, 2 or 3, z is 0 or 1, and y=3-w-z; and (c) water. The molar ratio of aluminum to water is from 1:1 to 100:1. The catalysts show an improved activity with respect to known catalysts wherein an aluminum compound different from those of the invention are used.
Patent IL-120881-A0 (IL)
Title: Method and apparatus for the non-invasive continuous monitoring of arterial pulse waves
IPC: A61B5/00
Filed: 1997-05-21
Abstract: A method and an apparatus for non-invasive detection of a physiological state or medical condition are disclosed. The method provides an indication of such state or condition such as myocardial ischemia or sleep apnea, by detecting the peripheral arterial tone's response to such state or condition, based on monitoring changes in peripheral arterial tone and determining that a change in the condition of the patient has occurred when a specific change in the peripheral arterial tone has been detected. A static pressure field is applied around the distal part of a digit of the subject. Peripheral arterial tone changes and related volume changes in the distal part of the digit are detected to thereby detect or monitor a physiological state or medical condition. The apparatus includes a finger probe (20), in the form of a tube (3) accommodating the patient's finger, which is designed to apply pressure, and a contiguous pressure cuff (40) which extends the boundary of the pressure field. The finger probe (2) either includes or is associated with a signal sensor/transducer (100, 101).